What is Compass Oncology?
Compass Oncology is a prominent provider of comprehensive cancer care services, serving the Portland-Vancouver metropolitan area. The organization leverages advanced treatment technologies and cutting-edge research to deliver personalized care plans for a spectrum of cancer types, including breast, lung, and prostate cancers. Guided by a mission to provide excellent care within the local community, Compass Oncology places a strong emphasis on the patient experience and offers robust support systems. With over 25 years of operational history, the company is committed to improving patient outcomes through compassionate treatment and innovative medical solutions.
How much funding has Compass Oncology raised?
Compass Oncology has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Compass Oncology
PPP
Public-Private Partnership
What's next for Compass Oncology?
The recent major strategic investment signals a pivotal phase for Compass Oncology, likely aimed at further enhancing its treatment capabilities, expanding its service reach, or integrating new technological advancements in oncology. This capital infusion is expected to fuel strategic growth initiatives, allowing the company to solidify its market position and continue its mission of delivering high-quality, patient-centric cancer care. The company's long-standing experience suggests a focus on sustainable expansion and operational excellence.
See full Compass Oncology company page
